Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke: incidence and association with atrial fibrillation [PDF]
, 2010 <p><b>Background and Purpose:</b> Mechanisms of early neurologic deterioration after treatment with intravenous, recombinant, tissue-type plasminogen activator (IV rt-PA) include symptomatic intracerebral hemorrhage (SICH) and early ...
Awadh, M. +5 more
core +1 more source
Comparison of predictive scores of symptomatic intracerebral haemorrhage after stroke thrombolysis in a single centre [PDF]
, 2015 Peer reviewedPublisher ...
Dai, D. +3 more
core +1 more source
Health Technology Assessment in Action, 2017 Context: Application of anti-clot drugs such as recombinant tissue plasminogen activator (rt-PA) to treat patients with strokes is considered as a standard treatment employed through two techniques: intra-arterial and intravenous thrombolysis.
Mojtaba Nouhi +4 more
doaj +1 more source
Professional guideline versus product label selection for treatment with IV thrombolysis: an analysis from SITS registry [PDF]
, 2017 Introduction: Thrombolysis usage in ischaemic stroke varies across sites. Divergent advice from professional guidelines and product labels may contribute. Patients and methods: We analysed SITS-International registry patients enrolled January 2010
Alan C Cameron +8 more
core +1 more source
Gait and Balance Disorder in Patients with Transient Ischemic Attack or Minor Stroke [Corrigendum]
Neuropsychiatric Disease and Treatment, 2022 Li N, Li J, Gao T, Wang D, Du Y, Zhao X. Neuropsychiatr Dis Treat. 2021;17:305–314. The authors have advised that the r value of intravenous thrombolysis in correlation with the Tandem scale in Table 4 and Table S2 is incorrect.
Li N, Li J, Gao T, Wang D, Du Y, Zhao X
doaj
Influence of age on outcome from thrombolysis in acute stroke: a controlled comparison in patients from the Virtual International Stroke Trials Archive (VISTA) [PDF]
, 2010 <p><b>Background and Purpose:</b> Thrombolysis for acute ischemic stroke in patients aged >80 years is not approved in some countries due to limited trial data in the very elderly.
Bluhmki, E. +4 more
core +1 more source
Development of a decision analytic model to support decision making and risk communication about thrombolytic treatment [PDF]
, 2015 Background Individualised prediction of outcomes can support clinical and shared decision making. This paper describes the building of such a model to predict outcomes with and without intravenous thrombolysis treatment following ischaemic stroke ...
A Bannat +7 more
core +2 more sources
Intravenous Thrombolysis in Nonagenarians With Ischemic Stroke [PDF]
Stroke, 2011 Background and Purpose— Demographic changes will result in a rapid increase of patients age ≥90 years (nonagenarians), but little is known about outcomes in these patients after intravenous thrombolysis (IVT) for acute ischemic stroke.
Sarikaya, Hakan +13 more
openaire +5 more sources
Frontiers in Neurology, 2014 Background and Purpose: Cardiac myxoma is a rare etiology of stroke. Both cerebral microbleeds and cardiac myxoma may increase the risk of intracerebral hemorrhage after intravenous thrombolysis. However, data is still limited.
Aurauma eChutinet +6 more
doaj +1 more source
Frontiers in Neurology, 2022 BackgroundHemorrhagic transformation (HT) is the most serious complication of ischemic stroke patients after intravenous thrombolysis and leads to a poor clinical prognosis.
Miaomiao Yang +4 more
doaj +1 more source